Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Clinical trials sponsored by Shanghai MicroPort CardioFlow Medtech Co., Ltd., explained in plain language.
A medical device company developing transcatheter heart valve products, a subsidiary of MicroPort Scientific.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart valve study aims to improve life for High-Risk patients Results expected Jun 2027 (estimated)